Drug Type Small molecule drug |
Synonyms KL-ON113 |
Target |
Action antagonists |
Mechanism HERs antagonists(Receptor tyrosine-protein kinase erbB antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | Discovery | India | - |





